Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
0.7089
+0.0189 (2.74%)
May 26, 2026, 3:32 PM EDT - Market open
Hoth Therapeutics Market Cap
Hoth Therapeutics has a market cap or net worth of $13.56 million as of May 26, 2026. Its market cap has increased by 6.25% in one year.
Market Cap
13.56M
Enterprise Value
9.44M
1-Year Change
6.25%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since February 15, 2019, Hoth Therapeutics's market cap has decreased from $80.39M to $13.56M, a decrease of -83.13%. That is a compound annual growth rate of -21.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 13.20M | -14.07% |
| Dec 31, 2025 | 15.36M | 166.64% |
| Dec 31, 2024 | 5.76M | -7.96% |
| Dec 29, 2023 | 6.26M | -38.29% |
| Dec 30, 2022 | 10.14M | -35.89% |
| Dec 31, 2021 | 15.82M | -50.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 14.54M |
| Theriva Biologics | 14.41M |
| Ernexa Therapeutics | 13.98M |
| Genenta Science | 13.68M |
| Cyclerion Therapeutics | 13.44M |
| CytoMed Therapeutics | 13.37M |
| Moleculin Biotech | 12.75M |
| Phio Pharmaceuticals | 12.66M |